Skip to main content
SpringerLink
Log in

Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Ivabradine, a bradycardic agent, has been shown to stably reduce patient’s heart rate (HR) in the setting of acute cardiac care. However, an association between atrial fibrillation (AF) risk and acute ivabradine treatment remains a controversial clinical issue, and has not been thoroughly investigated. Bradycardia and abnormal atrial refractoriness induced by ivabradine treatment may enhance vulnerability to AF induction, especially when vagal nerve is concurrently activated. We aimed to experimentally investigate the effects of acute ivabradine treatment with/without concurrent vagal activation on AF inducibility. In 16 anesthetized dogs, cervical vagal nerves were prepared for electrical stimulation (VS). AF induction rate (AFIR) was determined by atrial burst pacing. HR, atrial action potential duration (APD), atrial effective refractory period (ERP), and AFIR were obtained consecutively at baseline, during delivery of VS (VS alone), after intravenous injection of ivabradine 0.5 mg/kg (n = 8, ivabradine group) or saline (n = 8, saline group), and again during VS delivery (drug+VS). In the ivabradine group, ivabradine alone significantly lowered HR compared to baseline, while ivabradine+VS significantly lowered HR compared to VS alone. Contrary to expectations, there were no significant differences in trends of APD, temporal dispersion of APD, ERP, and AFIR between ivabradine and saline groups. Irrespective of whether ivabradine or saline was injected, VS significantly shortened APD and ERP, and increased AFIR. Interestingly, although bradycardia in response to ivabradine injection was more intense than that to VS alone, AFIR was significantly lower after ivabradine injection than during VS alone. We conclude that, despite its intense bradycardic effect, acute ivabradine treatment does not increase AF inducibility irrespective of underlying vagal activity. This study may constitute support for the safety of using ivabradine in the setting of acute cardiac care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. DiFrancesco D (2010) The role of the funny current in pacemaker activity. Circ Res 106:434–446

    Article  CAS  PubMed  Google Scholar 

  2. Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators SHIFT (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet 376:875–885

    Article  CAS  PubMed  Google Scholar 

  3. Fox K, Ford I, Steg PG, Tendera M, Ferrari R, Investigators BEAUTIFUL (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 372:807–816

    Article  CAS  PubMed  Google Scholar 

  4. Fasullo S, Cannizzaro S, Maringhini G, Ganci F, Giambanco F, Vitale G, Pinto V, Migliore G, Torres D, Sarullo FM, Paterna S, Di Pasquale P (2009) Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings. J Card Fail 15:856–863

    Article  CAS  PubMed  Google Scholar 

  5. Hidalgo FJ, Anguita M, Castillo JC, Rodríguez S, Pardo L, Durán E, Sánchez JJ, Ferreiro C, Pan M, Mesa D, Delgado M, Ruiz M (2016) Effect of early treatment with ivabradine combined with beta-blockers versus beta-blockers alone in patients hospitalised with heart failure and reduced left ventricular ejection fraction (ETHIC-AHF): a randomised study. Int J Cardiol 217:7–11

    Article  PubMed  Google Scholar 

  6. Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R, SIGNIFY investigators (2015) Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: an analysis from the SIGNIFY study. Eur Heart J 36:3291–3296

    PubMed  Google Scholar 

  7. Martin RI, Pogoryelova O, Koref MS, Bourke JP, Teare MD, Keavney BD (2014) Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials. Heart 100:1506–1510

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cammarano C, Silva M, Comee M, Donovan JL, Malloy MJ (2016) Meta-analysis of ivabradine in patients with stable coronary artery disease with and without left ventricular dysfunction. Clin Ther 38:387–395

    Article  CAS  PubMed  Google Scholar 

  9. Abdel-Salam Z, Nammas W (2016) Atrial fibrillation after coronary artery bypass surgery: can ivabradine reduce its occurrence? J Cardiovasc Electrophysiol 27:670–676

    Article  PubMed  Google Scholar 

  10. Steg P, Lopez-de-Sà E, Schiele F, Hamon M, Meinertz T, Goicolea J, Werdan K, Lopez-Sendon JL, VIVIFY (eValuation of the IntraVenous If inhibitor ivabradine after STsegment elevation mYocardial infarction) investigators (2013) Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study. Eur Heart J Acute Cardiovasc Care 2:270–279

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Stieber J, Wieland K, Stöckl G, Ludwig A, Hofmann F (2006) Bradycardic and proarrhythmic properties of sinus node inhibitors. Mol Pharmacol 69:1328–1337

    Article  CAS  PubMed  Google Scholar 

  12. John RM, Kumar S (2016) Sinus node and atrial arrhythmias. Circulation 133:1892–1900

    Article  PubMed  Google Scholar 

  13. Fedorov VV, Chang R, Glukhov AV, Kostecki G, Janks D, Schuessler RB, Efimov IR (2010) Complex interactions between the sinoatrial node and atrium during reentrant arrhythmias in the canine heart. Circulation 122:782–789

    Article  PubMed  PubMed Central  Google Scholar 

  14. Cacciani F, Zaniboni M (2015) Chronotropic modulation of the source-sink relationship of sinoatrial-atrial impulse conduction and its significance to initiation of AF: a one-dimensional model study. Biomed Res Int 2015:496418

    Article  PubMed  PubMed Central  Google Scholar 

  15. Han J, Millet D, Chizzonitti B, Moe GK (1966) Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate. Am Heart J 71:481–487

    Article  CAS  PubMed  Google Scholar 

  16. Elvan A (2001) Sinoatrial remodeling caused by persistent atrial fibrillation: what is the relationship between postcardioversion sinus node dysfunction and increased atrial vulnerability? J Cardiovasc Electrophysiol 12:807–808

    Article  CAS  PubMed  Google Scholar 

  17. Spach MS, Dolber PC, Heidlage JF (1989) Interactions of inhomogeneities of repolarization with anisotropic propagation in dog atria: a mechanism for both preventing and initiating re-entry. Circ Res 65:1612–1631

    Article  CAS  PubMed  Google Scholar 

  18. Li YD, Ji YT, Zhou XH, Jiang T, Hong YF, Li JX, Xing Q, Xiong J, Yusufuaji Y, Tang BP (2015) Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation. Med Sci Monit 21:1414–1420

    Article  PubMed  PubMed Central  Google Scholar 

  19. Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S (2014) Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res 114:1500–1515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Liu L, Nattel S (1997) Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol 273:H805–H816

    CAS  PubMed  Google Scholar 

  21. Bonnemeier H, Hartmann F, Wiegand UK, Irmer C, Kurz T, Tölg R, Katus HA, Richardt G (2000) Heart rate variability in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 85:815–820

    Article  CAS  PubMed  Google Scholar 

  22. Chiladakis JA, Patsouras N, Manolis AS (2003) The Bezold-Jarisch reflex in acute inferior myocardial infarction: clinical and sympathovagal spectral correlates. Clin Cardiol 26:323–328

    Article  PubMed  Google Scholar 

  23. Uemura K, Inagaki M, Zheng C, Li M, Kawada T, Sugimachi M (2015) A novel technique to predict pulmonary capillary wedge pressure utilizing central venous pressure and tissue Doppler tricuspid/mitral annular velocities. Heart Vessels 30:516–526

    Article  PubMed  Google Scholar 

  24. Narayan SM, Franz MR (2007) Quantifying fractionation and rate in human atrial fibrillation using monophasic action potentials: implications for substrate mapping. Europace 9:vi89–vi95

    PubMed  Google Scholar 

  25. Kanki H, Mitamura H, Takatsuki S, Sueyoshi K, Shinagawa K, Sato T, Ogawa S (1998) Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics. Cardiovasc Drugs Ther 12:475–482

    Article  CAS  PubMed  Google Scholar 

  26. Lu Z, Scherlag BJ, Lin J, Niu G, Fung KM, Zhao L, Ghias M, Jackman WM, Lazzara R, Jiang H, Po SS (2008) Atrial fibrillation begets atrial fibrillation: autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing. Circ Arrhythm Electrophysiol 1:184–192

    Article  PubMed  PubMed Central  Google Scholar 

  27. Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A (2004) Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 308:236–240

    Article  CAS  PubMed  Google Scholar 

  28. Zaniboni M, Cacciani F, Lux RL (2014) Beat-to-beat cycle length variability of spontaneously beating guinea pig sinoatrial cells: relative contributions of the membrane and calcium clocks. PLoS One 9:e100242

    Article  PubMed  PubMed Central  Google Scholar 

  29. Zaniboni M, Pollard AE, Yang L, Spitzer KW (2000) Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. Am J Physiol Heart Circ Physiol 278:H677–H687

    CAS  PubMed  Google Scholar 

  30. Franz MR (1983) Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 51:1629–1634

    Article  CAS  PubMed  Google Scholar 

  31. Ashikaga K, Kobayashi T, Kimura M, Owada S, Sasaki S, Iwasa A, Furukawa K, Motomura S, Okumura K (2006) Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. Eur J Pharmacol 536:148–153

    Article  CAS  PubMed  Google Scholar 

  32. Kabell G, Buchanan LV, Gibson JK, Belardinelli L (1994) Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovasc Res 28:1385–1389

    Article  CAS  PubMed  Google Scholar 

  33. Bode F, Kilborn M, Karasik P, Franz MR (2001) The repolarization-excitability relationship in the human right atrium is unaffected by cycle length, recording site and prior arrhythmias. J Am Coll Cardiol 37:920–925

    Article  CAS  PubMed  Google Scholar 

  34. Tsuboi M, Furukawa Y, Nakajima K, Kurogouchi F, Chiba S (2000) Inotropic, chronotropic, and dromotropic effects mediated via parasympathetic ganglia in the dog heart. Am J Physiol Heart Circ Physiol 279:H1201–H1207

    CAS  PubMed  Google Scholar 

  35. Franz MR (1999) Current status of monophasic action potential recording: theories, measurements and interpretations. Cardiovasc Res 41:25–40

    Article  CAS  PubMed  Google Scholar 

  36. Goldberg JM, Lynn-Johnson MH, Neely B (1981) Use of P wave morphology for inferring pacemaker localization along the sulcus terminalis in the dog. J Electrocardiol 14:115–124

    Article  CAS  PubMed  Google Scholar 

  37. Camm AJ, Lau CP (2003) Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs R D 4:83–89

    Article  CAS  PubMed  Google Scholar 

  38. Roithinger FX, Karch MR, Steiner PR, SippensGroenewegen A, Lesh MD (1999) The spatial dispersion of atrial refractoriness and atrial fibrillation vulnerability. J Interv Card Electrophysiol 3:311–319

    Article  CAS  PubMed  Google Scholar 

  39. Sugimura S, Kurita T, Kaitani K, Yasuoka R, Miyazaki S (2016) Ectopies from the superior vena cava after pulmonary vein isolation in patients with atrial fibrillation. Heart Vessels 31:1562–1569

    Article  PubMed  Google Scholar 

  40. Jiang Z, Yin H, He Y, Ma N, Tang M, Liu H, Ding F, Mei J (2015) Efficacy and safety of novel epicardial circumferential left atrial ablation with pulmonary vein isolation in sustained atrial fibrillation. Heart Vessels 30:675–681

    Article  PubMed  Google Scholar 

  41. Suenari K, Cheng CC, Chen YC, Lin YK, Nakano Y, Kihara Y, Chen SA, Chen YJ (2012) Effects of ivabradine on the pulmonary vein electrical activity and modulation of pacemaker currents and calcium homeostasis. J Cardiovasc Electrophysiol 23:200–206

    Article  PubMed  Google Scholar 

  42. Zhang Y, Ilsar I, Sabbah HN, Ben David T, Mazgalev TN (2009) Relationship between right cervical vagus nerve stimulation and atrial fibrillation inducibility: therapeutic intensities do not increase arrhythmogenesis. Heart Rhythm 6:244–250

    Article  PubMed  Google Scholar 

  43. De Ferrari GM, Mazzuero A, Agnesina L, Bertoletti A, Lettino M, Campana C, Schwartz PJ, Tavazzi L (2008) Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure. Eur J Heart Fail 10:550–555

    Article  PubMed  Google Scholar 

  44. Colin P, Ghaleh B, Monnet X, Su J, Hittinger L, Giudicelli JF, Berdeaux A (2003) Contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 284:H676–H682

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, 565-8565, Japan

    Kazunori Uemura, Masashi Inagaki, Can Zheng, Toru Kawada, Meihua Li, Masafumi Fukumitsu & Masaru Sugimachi

Authors
  1. Kazunori Uemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masashi Inagaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Can Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toru Kawada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Meihua Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masafumi Fukumitsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masaru Sugimachi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazunori Uemura.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

This work was supported by JSPS KAKENHI Grant No. 15K01307, and also by Practical Research Project for Life-Style related Diseases including Cardiovascular Diseases and Diabetes Mellitus from Japan Agency for Medical Research and Development.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uemura, K., Inagaki, M., Zheng, C. et al. Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs. Heart Vessels 32, 484–494 (2017). https://doi.org/10.1007/s00380-016-0922-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-016-0922-y

Keywords

Search

Navigation